• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number CEB231210A
Device Problems Collapse (1099); Occlusion Within Device (1423); Failure to Advance (2524)
Patient Problems Paralysis (1997); Thrombus (2101); Stenosis (2263); Claudication (2550)
Event Date 09/20/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
On (b)(6) 2016, the patient underwent repair of an abdominal aortic aneurysm and right common iliac artery (rcia) aneurysm with gore excluder aaa endoprostheses.Reportedly, the gore iliac branch endoprosthesis was advanced and deployed without issue.It was reported several unsuccessful attempts were made to obtain guidewire access into the reportedly patent right internal iliac artery (riia).Reportedly there was nothing about the patient's anatomy that contributed to the difficulty advancing the guide wire.The physician elected to remove the guidewire and perform intra-operative imaging.It was reported, imaging identified the riia had collapsed and was no longer patent; however the left internal iliac artery (liia) was reported to be fully patent.The physician elected to advance, from the patient's left side, a contralateral leg component up and over the aortic bifurcation.The device was reportedly deployed upside down within the iliac branch component with intentional coverage of the right internal iliac gate and riia.A trunk-ipsilateral leg component was then advanced and deployed without issue.An additional contralateral leg component was implanted as a bridge between the trunk-ipsilateral leg component and the iliac branch component.Another contralateral leg component was then advanced and deployed 1.5cm proximal to the ostium of the left internal iliac artery (liia).Post-deployment ballooning was performed utilizing a qx medical q50-65p stent graft balloon.It was reported, the balloon was not overinflated or extended outside of the devices during the ballooning process.Final angiography showed an area of slight stenosis located between the distal end of the contralateral leg component and the liia.It was reported, the physician suspected this area of stenosis was caused by a thrombotic clot.Additional imaging revealed the stenotic area to be free of any calcification.The physician elected to balloon the area of stenotic native vessel utilizing a small non-gore balloon (manufacturer unknown).Immediately, following the ballooning, imaging showed the liia had occluded.The non-gore balloon was then used in an effort to dilate the liia.Immediately, following ballooning imaging indicated the liia appeared opened and patent.The physician concluded the procedure without the implantation of a stent within the liia to maintain blood flow.On (b)(6) 2016, it was reported the patient experienced bilateral claudication, and an inability to stand.Ct imaging performed later that same day, indicated the liia had re-occluded.On (b)(6) 2016, the physician notified the fsa that the patient appears to be permanently paralyzed from the waist down.The cause of the paralysis is reportedly unknown.To date a cerebrospinal fluid drain has not been placed, nor have any additional procedures been performed to treat the patient's paralysis.Reportedly, the patient has been administered steroid medication for treatment of the paralysis.The physician will continue to monitor the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL SUNNYVALE B/P
1327 orleans drive
sunnyvale CA 94089
Manufacturer Contact
charlene cooper
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key5997065
MDR Text Key56402852
Report Number2953161-2016-00198
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 09/20/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/09/2019
Device Catalogue NumberCEB231210A
Device Lot Number15160206
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/04/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/09/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age74 YR
Patient Weight71
-
-